Imagenebio Inc (IMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,876 | -16,146 | -68,166 | -48,677 | -31,334 |
| Depreciation Amortization | -506 | 219 | -1,003 | -994 | -659 |
| Accounts payable and accrued liabilities | -658 | -157 | -2,870 | -987 | -321 |
| Other Working Capital | -5,452 | -5,271 | -21,669 | -15,287 | -10,499 |
| Other Operating Activity | 5,686 | 3,051 | 13,965 | 8,021 | 4,886 |
| Operating Cash Flow | $-30,806 | $-18,304 | $-79,743 | $-57,924 | $-37,927 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 245 | 60 | -414 | -148 | -148 |
| Purchase Of Investment | -72,265 | -62,298 | -90,052 | -65,217 | -47,050 |
| Sale Of Investment | 27,200 | 13,500 | 154,610 | 109,133 | 59,072 |
| Investing Cash Flow | $-44,820 | $-48,738 | $64,144 | $43,768 | $11,874 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 37,557 | 37,557 | 37,665 |
| Common Stock Repurchased | N/A | N/A | -663 | -663 | -663 |
| Other Financing Activity | 0 | 0 | 39,086 | 39,026 | 0 |
| Financing Cash Flow | $N/A | $N/A | $75,980 | $75,920 | $37,002 |
| Beginning Cash Position | 121,172 | 121,172 | 60,791 | 60,791 | 60,791 |
| End Cash Position | 45,546 | 54,130 | 121,172 | 122,555 | 71,740 |
| Net Cash Flow | $-75,626 | $-67,042 | $60,381 | $61,764 | $10,949 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,806 | -18,304 | -79,743 | -57,924 | -37,927 |
| Capital Expenditure | N/A | N/A | -414 | -152 | -152 |
| Free Cash Flow | -30,806 | -18,304 | -80,157 | -58,076 | -38,079 |